Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance

By Catia Marzolini, E. Paus, T. Buclin, R. Kim. Clinical pharmacology and therapy, 2004

934 citations recorded by the source corpus.

Subfields: Oncology, Pediatrics, Perinatology and Child Health, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/8add0f7e97461299a319545c3932bdcaa65ea47f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. Berislav Zlokovic
2. D. Holtzman

In Pediatrics, Perinatology and Child Health

1. R. Deane
2. Berislav Zlokovic

In Psychiatry and Mental health

1. D. Holtzman
2. Berislav Zlokovic
3. J. Long

Citations in the corpus

• P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. (2005, background): “Clearance of Alzheimer’s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.”